Katy, Texas Mar 24, 2026 (Issuewire.com) - Dr. Linda Moatamed, PharmD, is a registered pharmacist and medication therapy management specialist dedicated to delivering safe, effective, and patient-centered care. As Pharmacist-in-Charge at Walgreens in Tomball, Texas, she oversees pharmacy operations, clinical services, and regulatory compliance, ensuring patients receive high-quality care while maintaining the highest standards of safety and efficiency.
With over two years of experience in pharmacy operations, Dr. Moatamed has developed a strong skill set in drug utilization review, medication therapy management, patient counseling, point-of-care testing, and immunization services. She is known for her detail-oriented and collaborative approach, working closely with both patients and pharmacy teams to optimize workflow, enhance service delivery, and improve overall patient outcomes. Her commitment to continuous improvement and excellence has made her a valued leader in community pharmacy practice.
Dr. Moatamed is passionate about building meaningful relationships with her patients and guiding them through complex healthcare decisions. I most enjoy building meaningful, long-term relationships with my patients and having the opportunity to make a tangible difference in their health and quality of life, she shares. I find great purpose in helping patients understand their conditions, empowering them to take an active role in their care, and guiding them through complex health decisions. Her approach blends scientific expertise with empathy, ensuring patients feel supported and informed during some of their most vulnerable moments.
Dr. Moatamed earned her Doctor of Pharmacy Degree from Texas Southern University and completed a range of clinical internships that strengthened her hands-on training. Her rotations included Memorial Hermann Health System, Harris Health System, Houston Methodist Hospital, and Katy Encompass Rehabilitation Hospital, where she gained valuable experience in interdisciplinary collaboration and patient-focused care. Additionally, her early career experience in pharmaceutical manufacturing in Iran provided a strong foundation in operational efficiency, quality assurance, and regulatory standards.
Beyond her clinical responsibilities, Dr. Moatamed is actively engaged in professional and community organizations. She has held leadership roles within MEPA, demonstrating her commitment to mentorship, advocacy, and professional development. She is also a member of the Iranian Cultural Foundation and supports the Persian community through volunteer service.
Through her leadership, clinical expertise, and dedication to patient care, Dr. Linda Moatamed continues to make a meaningful impact in pharmacy practice and the communities she serves.
Learn more about Dr. Linda Moatamed:
Through her Americas Best in Medicine profile, https://americasbestinmedicine.com/connect/linda-moatamed
More On Showupnews ::
- Lisa Carter, Recognized by BestAgents.us as a 2025 Top Agent
- Justin Nimergood, Recognized by BestAgents.us as a 2025 Top Agent
- Injured in Houston? The Law Office of Udo Ezeamama Delivers Aggressive Representation for Personal Injury Victims
- The Complete Guide to OEM vs. ODM Eyewear Production
- Official FORTHING T5 EVO Turbocharger Parts: Where to Buy with International Shipping
Americas Best in Medicine
Americas Best in Medicine is a specialist online platform dedicated to amplifying the voices of leading healthcare professionals across the United States. They bring together top healthcare providers from all specialties and cities to share expert-driven articles, research, commentary, and clinical insight. Their core purposes are to showcase excellence in healthcare, build trust between providers and the public, and ensure that expert voices are elevated and heard in shaping medicine. Through their platform, users can access a community of leaders, opportunities for providers to share expertise, and trusted guidance for patients and peers alike.
Source :Dr. Linda Moatamed
This article was originally published by IssueWire. Read the original article here.